Agile Therapeutics, Inc. Revenue
Agile Therapeutics, Inc. reported Revenue of $5.58 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2024-08-12
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-06-30 was $5.58M, a 1.33% increase year-over-year.
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-03-31 was $5.72M, a 49.91% increase year-over-year.
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-12-31 was $3.61M, a 9.56% decline year-over-year.
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-09-30 was $6.66M, a 121.92% increase year-over-year.
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $19.59M, a 80.02% increase from fiscal 2022.
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $10.88M, a 165.40% increase from fiscal 2021.
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $4.10M, a 447.53% increase from fiscal 2020.
- Agile Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $749.00K.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2024-06-30 | $5.58M 10-Q · filed 2024-08-12 | $11.29M 10-Q · filed 2024-08-12 | $14.91M derived: sum of 3 quarters · filed 2024-08-12 | $21.57M derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | $5.72M 10-Q · filed 2024-05-15 | $9.33M derived: sum of 2 quarters · filed 2024-05-15 | $15.99M derived: sum of 3 quarters · filed 2024-05-15 | $21.50M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $10.28M derived: sum of 2 quarters · filed 2024-03-28 | $15.78M derived: sum of 3 quarters · filed 2024-08-12 | $19.59M 10-K · filed 2024-03-28 |
| 2023-09-30 | $6.66M 10-Q · filed 2023-11-09 | $12.16M derived: sum of 2 quarters · filed 2024-08-12 | $15.98M 10-Q · filed 2023-11-09 | $19.97M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-06-30 | $5.50M 10-Q · filed 2024-08-12 | $9.32M 10-Q · filed 2024-08-12 | $13.31M derived: sum of 3 quarters · filed 2024-08-12 | $16.31M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $3.81M 10-Q · filed 2024-05-15 | $7.81M derived: sum of 2 quarters · filed 2024-05-15 | $10.81M derived: sum of 3 quarters · filed 2024-05-15 | $12.94M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $7.00M derived: sum of 2 quarters · filed 2024-03-28 | $9.12M derived: sum of 3 quarters · filed 2024-03-28 | $10.88M 10-K · filed 2024-03-28 |
| 2022-09-30 | $3.00M 10-Q · filed 2023-11-09 | $5.13M derived: sum of 2 quarters · filed 2023-11-09 | $6.89M 10-Q · filed 2023-11-09 | $8.40M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $2.13M 10-Q · filed 2023-08-09 | $3.89M 10-Q · filed 2023-08-09 | $5.40M derived: sum of 3 quarters · filed 2024-03-28 | $6.69M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $1.76M 10-Q · filed 2023-05-11 | $3.27M derived: sum of 2 quarters · filed 2024-03-28 | $4.56M derived: sum of 3 quarters · filed 2024-03-28 | $5.75M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.80M derived: sum of 2 quarters · filed 2024-03-28 | $3.99M derived: sum of 3 quarters · filed 2024-03-28 | $4.10M 10-K · filed 2024-03-28 |
| 2021-09-30 | $1.29M 10-Q · filed 2022-11-07 | $2.47M derived: sum of 2 quarters · filed 2022-11-07 | $2.59M 10-Q · filed 2022-11-07 | $3.34M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.19M 10-Q · filed 2022-08-11 | $1.30M 10-Q · filed 2022-08-11 | $2.05M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $116.00K 10-Q · filed 2022-05-12 | $865.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $749.00K 10-K · filed 2021-03-01 | $749.00K 10-K · filed 2023-03-23 |